Should I buy or sell Nihon M&A Center stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nihon M&A Center in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street analysts is that investors should "sell" NHMAF shares. View NHMAF analyst ratings or view top-rated stocks .

How have NHMAF shares performed in 2024?

Nihon M&A Center's stock was trading at $5.0710 at the beginning of the year. Since then, NHMAF stock has increased by 7.9% and is now trading at $5.47. View the best growth stocks for 2024 here .

Are investors shorting Nihon M&A Center?

Nihon M&A Center saw a drop in short interest in March. As of March 15th, there was short interest totaling 1,986,300 shares, a drop of 21.3% from the February 29th total of 2,525,100 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 19,863.0 days. View Nihon M&A Center's Short Interest .

Is Nihon M&A Center a good dividend stock?

Nihon M&A Center (OTCMKTS:NHMAF) pays an annual dividend of $60.54 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 61.81%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Nihon M&A Center?

Shares of NHMAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:NHMAF

Nihon M&A Center (NHMAF) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free NHMAF Stock Alerts

$5.47

+0.05 (+0.92%)

(As of 04/19/2024 05:38 PM ET)

Compare

Today's Range: $5.47
▼
$5.47
50-Day Range: $5.42
▼
$6.87
52-Week Range: $4.20
▼
$8.23

Volume: 203 shs
Average Volume: 228 shs
Market Capitalization: N/A

P/E Ratio: 0.06
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Short Interest

Get Nihon M&A Center alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About Nihon M&A Center Stock (OTCMKTS:NHMAF)

Nihon M&A Center Holdings Inc. provides mergers and acquisition (M&A) related services in Japan and internationally. The company offers M&A support services, such as reorganization, capital policies, and MBO for small and medium-sized enterprises. Nihon M&A Center Holdings Inc. was incorporated in 1991 and is headquartered in Tokyo, Japan.

NHMAF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NHMAF Stock News Headlines

March 30, 2024 | seekingalpha.com

PRDL Profitable Developments, Inc.

December 9, 2023 | finance.yahoo.com

Nihon M&A Center Holdings Inc. (2127.T)

April 20, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

October 26, 2023 | markets.businessinsider.com

Nihon M&A Center earnings: here's what to expect

September 27, 2023 | jp.reuters.com

Nihon M&A Center Holdings Inc

September 12, 2023 | investing.com

Nihon M&A Center Inc (2127)

September 10, 2023 | thestreet.com

Nihon M&A Center Holdings Inc.

See More Headlines

Receive NHMAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nihon M&A Center and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Financial Services
Industry: Capital Markets
Sub-Industry: N/A
Current Symbol: OTCMKTS:NHMAF
CUSIP: N/A
CIK: N/A
Web: www.nihon-ma.co.jp
Phone: (135) 220-5454
Fax: N/A
Employees: 1,083
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 0.06
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Mr. Suguru Miyake (Age 72)
President & Representative Director
Comp: $976.65k
Mr. Yasuhiro Wakebayashi (Age 81)
Founder & Honorary Chairman
Comp: $778.68k
Mr. Takamaro Naraki (Age 62)
Senior MD, GM of Administrative Division & Director
Yokoi Shin
General Manager of Legal Affairs Office
Naoki Takeuchi (Age 46)
MD, GM of Sales Headquarters and Strategic Management Division & Director
Mr. Takayoshi Ohyama (Age 57)
MD & GM of Corporate Planning Division
Mr. Masahiko Ohtsuki (Age 54)
MD & Director
Hachidai Sawamura
Senior Corporate Executive Officer & Head of Transaction Management Div.
Yoshiharu Amanomori
Senior Corporate Officer & Head of TPM Div.
Yasunobu Watase
Senior Corporate Executive Officer & Supervisor of Growth Strategy Div.

Key Competitors

View All Competitors

NHMAF Stock Analysis - Frequently Asked Questions

Should I buy or sell Nihon M&A Center stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nihon M&A Center in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street analysts is that investors should "sell" NHMAF shares.
View NHMAF analyst ratings or view top-rated stocks.
How have NHMAF shares performed in 2024?: Nihon M&A Center's stock was trading at $5.0710 at the beginning of the year. Since then, NHMAF stock has increased by 7.9% and is now trading at $5.47.
View the best growth stocks for 2024 here.
Are investors shorting Nihon M&A Center?: Nihon M&A Center saw a drop in short interest in March. As of March 15th, there was short interest totaling 1,986,300 shares, a drop of 21.3% from the February 29th total of 2,525,100 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 19,863.0 days.
View Nihon M&A Center's Short Interest.

Is Nihon M&A Center a good dividend stock?: Nihon M&A Center (OTCMKTS:NHMAF) pays an annual dividend of $60.54 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 61.81%. This payout ratio is at a healthy, sustainable level, below 75%.
How do I buy shares of Nihon M&A Center?: Shares of NHMAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NHMAF) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial